Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Staudt

Nature

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature|October 22, 2004
Cancer: negative feedback for B cellsLouis M Staudt
Nature|July 26, 2023
Double-headed molecule activates cell-death pathways in cancer cellsJames D Phelan, Louis M Staudt
Nature|March 31, 2006
A loss-of-function RNA interference screen for molecular targets in cancerVu N Ngo, R Eric Davis, Laurence Lamy, et al.
Nature|June 24, 2008
IRF4 addiction in multiple myelomaArthur L Shaffer, N C Tolga Emre, Laurence Lamy, et al.
Nature|January 2, 2009
Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survivalNicolas Bidère, Vu N Ngo, Jeansun Lee, et al.
Nature|October 3, 2014
Loss of signalling via Gα13 in germinal centre B-cell-derived lymphomaJagan R Muppidi, Roland Schmitz, Jesse A Green, et al.
Nature|March 4, 2011
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancersChristian Steidl, Sohrab P Shah, Bruce W Woolcock, et al.
Nature|December 10, 2020
Histone H1 loss drives lymphoma by disrupting 3D chromatin architectureNevin Yusufova, Andreas Kloetgen, Matt Teater, et al.
Nature|December 24, 2010
Oncogenically active MYD88 mutations in human lymphomaVu N Ngo, Ryan M Young, Roland Schmitz, et al.
Nature|June 22, 2018
A multiprotein supercomplex controlling oncogenic signalling in lymphomaJames D Phelan, Ryan M Young, Daniel E Webster, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature|October 22, 2004
Cancer: negative feedback for B cellsLouis M Staudt
Nature|July 26, 2023
Double-headed molecule activates cell-death pathways in cancer cellsJames D Phelan, Louis M Staudt
Nature|March 31, 2006
A loss-of-function RNA interference screen for molecular targets in cancerVu N Ngo, R Eric Davis, Laurence Lamy, et al.
Nature|June 24, 2008
IRF4 addiction in multiple myelomaArthur L Shaffer, N C Tolga Emre, Laurence Lamy, et al.
Nature|January 2, 2009
Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survivalNicolas Bidère, Vu N Ngo, Jeansun Lee, et al.
Nature|October 3, 2014
Loss of signalling via Gα13 in germinal centre B-cell-derived lymphomaJagan R Muppidi, Roland Schmitz, Jesse A Green, et al.
Nature|March 4, 2011
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancersChristian Steidl, Sohrab P Shah, Bruce W Woolcock, et al.
Nature|December 10, 2020
Histone H1 loss drives lymphoma by disrupting 3D chromatin architectureNevin Yusufova, Andreas Kloetgen, Matt Teater, et al.
Nature|December 24, 2010
Oncogenically active MYD88 mutations in human lymphomaVu N Ngo, Ryan M Young, Roland Schmitz, et al.
Nature|June 22, 2018
A multiprotein supercomplex controlling oncogenic signalling in lymphomaJames D Phelan, Ryan M Young, Daniel E Webster, et al.
Pageof 2